XML 116 R94.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-based Compensation Expense - Schedule of the Company's Option Activity (Details)
$ / shares in Units, shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2024
USD ($)
$ / shares
shares
Options Outstanding [Roll Forward]  
Outstanding, beginning balance (shares) | shares 5.0
Granted (shares) | shares 1.0
Exercised (shares) | shares (1.2)
Canceled/expired (shares) | shares (0.2)
Outstanding, ending balance (shares) | shares 4.5
Vested and unvested expected to vest (shares) | shares 4.4
Exercisable (shares) | shares 2.6
Weighted average exercise price  
Outstanding, beginning of period (in dollars per share) | $ / shares $ 401.30
Granted (in dollars per share) | $ / shares 554.31
Exercised (in dollars per share) | $ / shares 260.55
Canceled/expired (in dollars per share) | $ / shares 559.45
Outstanding, end of period (in dollars per share) | $ / shares 465.80
Vested and unvested expected to vest (in dollars per share) | $ / shares 462.90
Exercisable (in dollars per share) | $ / shares $ 403.06
Options, Additional Disclosures [Abstract]  
Options outstanding, weighted average remaining contractual term 4 years 3 months 18 days
Options vested and expected to vest, weighted average remaining contractual term 4 years 2 months 12 days
Options exercisable, weighted average remaining contractual term 2 years 10 months 24 days
Options outstanding, aggregate intrinsic value | $ $ 358
Options vested and expected to vest, aggregate intrinsic value | $ 358
Options exercisable, aggregate intrinsic value | $ $ 350